8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Pooled results from many studies on one question.
2023 / Systematic review and meta-analysis
A systematic review and meta-analysis of 10 studies comprising 32,006 participants evaluated the link between plant-based dietary patterns and gestational diabetes mellitus (GDM). Better adherence to plant-based diets was related to a lower risk of developing GDM (RR = 0.88 [0.81 to 0.96], I2 = 14.8%). A slightly stronger association was observed for healthy plant-based dietary patterns (RR = 0.86 [0.79 to 0.94], I2 = 8.3%) compared to unhealthy plant-based patterns (RR = 0.90 [0.82 to 0.98], I2 = 8.3%).
Shows an association, not proof of cause and effect.
Zhu Y, Zheng Q, Huang L, et al. PLoS One, 2023. PMID 37792722
2023 / Umbrella review of meta-analyses
An umbrella review searched six databases to evaluate the link between vegetarian diets and cardiovascular and cerebrovascular outcomes. Findings showed risk reductions of 41.2% for cerebrovascular disease, 29% for CVD incidence, 13.8% for CVD mortality, and 24.1% for IHD incidence (with high heterogeneity). Significant reductions were also observed for IHD mortality (32.1%), ischemic stroke (32.9%), and stroke incidence (39.1% in a single study), while stroke mortality had a non-significant 11.6% reduction with moderate heterogeneity. The authors noted that evidence quality and consistency varied.
Shows an association, not proof of cause and effect.
Ocagli H, Berti G, Rango D, et al. Nutrients, 2023. PMID 37836394
2023 / Systematic review of clinical trials
A systematic review compared the efficacy and safety of semaglutide with bariatric surgery using data from trials including STEP, SUSTAIN, PIONEER, STAMPEDE, and the LABS consortium. Semaglutide demonstrated significant weight reduction, though adverse events included gastrointestinal disturbances, increased pulse rate, rare thyroid cancer cases, and partial weight regain after withdrawal. Bariatric surgery showed higher efficacy in weight reduction and diabetes management targets compared to medical therapy alone, but also carried a higher risk of complications.
Klair N, Patel U, Saxena A, et al. Cureus, 2023. PMID 37905277
2023 / Systematic review and dose-response meta-analysis of RCTs
A systematic review and meta-analysis of 13 RCTs evaluated the effects of purslane consumption on lipid profiles and C-reactive protein (CRP). Compared to the control group, purslane consumption significantly reduced serum triglycerides (WMD: -16.72, 95% CI: -22.49, -10.96 mg/dL, p < .001), total cholesterol (WMD: -9.97, 95% CI: -19.86, -0.07 mg/dL, p = .048), and CRP (WMD: -1.22, 95% CI: -1.63, -0.80 mg/L, p < .001). It also significantly increased HDL-C (WMD: 4.09, 95% CI: 1.77, 6.41 mg/dL, p = .001), while LDL-C levels were not affected. According to a suggested optimal dosage, purslane consumption is considered to be safe up to 30 g/day.
Jafari N, Bahreini N, Dehghani A, et al. Food Sci Nutr, 2023. PMID 37970383
2023 / Systematic review and meta-analysis
A systematic review and meta-analysis of 18 research articles evaluated the dose-response relationship between ultra-processed food (UPF) consumption and noncommunicable diseases. UPF consumption significantly increased daily intake of carbohydrates (49.64%), added sugar (40.78%), saturated fat (30.00%), sodium (27.76%), energy (26.67%), cholesterol (25.69%), and total fat (15.77%), while fiber intake was -38.55% below recommendations. Each 10% increase in UPF intake was significantly linked to higher risks of diabetes (HR ± 95% CI: 1.115 ± 0.044), cardiovascular diseases (1.096 ± 0.053), obesity (1.068 ± 0.050), and cancer (1.020 ± 0.020).
Shows an association, not proof of cause and effect.
Bestari FF, Andarwulan N, Palupi E Foods, 2023. PMID 38137261
2023 / Systematic review and meta-analysis of randomized trials
A meta-analysis evaluated four randomized trials (N = 227) examining Emblica officinalis aqueous fruit extract versus placebo over 12 weeks in adults with dyslipidemia. The extract significantly decreased total cholesterol (SMD = -21.23 mg/dL, 95% CI: -34.22 to -8.25; P = 0.001) and LDL-C (SMD = -25.12 mg/dL, 95% CI: -40.24 to -10.00; P = 0.001), and increased HDL-C (SMD = 4.74 mg/dL, 95% CI: 0.40 to 9.07; P = 0.03). No statistically significant difference was seen in serum triglycerides (SMD = -22.28 mg/dL, 95% CI: -53.33 to 8.76; P = 0.16). High heterogeneity was present across all lipid outcomes (I2 between 72% and 93%), and findings were based on low certainty of evidence.
Acampado LRT, Chiu HHC, Larrazabal RB, et al. Acta Med Philipp, 2023. PMID 39678212
2022 / Systematic review and meta-analysis of observational studies
A systematic review and meta-analysis examined 13 observational publications (4 cohort and 9 cross-sectional studies) evaluating the relationship between a vegetarian diet and depression, anxiety, and stress. The pooled effect size from 10 studies showed no association between a vegetarian diet and depression (pooled effect size: 1.02, 95% CI: 0.84-1.25, p = 0.817). Similarly, pooled results from 4 studies indicated no association with anxiety (pooled effect size: 1.09, 95% CI: 0.71-1.68, p = 0.678). Results for stress could not be pooled due to insufficient data.
Shows an association, not proof of cause and effect.
Askari M, Daneshzad E, Darooghegi Mofrad M, et al. Crit Rev Food Sci Nutr, 2022. PMID 32885996
2022 / Systematic review and dose-response meta-analysis of prospective cohort studies
A systematic review and dose-response meta-analysis of prospective cohort studies examined the relationship of milk and dairy intake with mortality risk. High-fat milk consumption was significantly associated with a greater risk of all-cause (Pooled ES: 1.15; 95% CI: 1.09-1.20), CVD (Pooled ES: 1.09; 95% CI: 1.02-1.16), and cancer mortality (Pooled ES: 1.17; 95% CI: 1.08-1.28). Conversely, total dairy consumption was linked to a lower risk of CVD mortality (Pooled ES: 0.93; 95% CI: 0.88-0.98), showing a significant non-linear association with all-cause and CVD mortality. High-fat milk intake was also significantly associated with cancer mortality risk in both linear and non-linear dose-response analyses.
Shows an association, not proof of cause and effect.
Naghshi S, Sadeghi O, Larijani B, et al. Crit Rev Food Sci Nutr, 2022. PMID 33397132
2022 / Systematic review and meta-analysis of RCTs
A systematic review and meta-analysis of 23 RCTs evaluated the effect of melatonin supplementation on sleep quality using the Pittsburgh Sleep Quality Index (PSQI). Melatonin significantly improved sleep quality overall (WMD: -1.24; 95% CI -1.77, -0.71, p = 0.000), though significant heterogeneity was observed (I2 = 80.7%, p = 0.000). Subgroup analyses revealed significant sleep quality improvements in subjects with respiratory diseases (WMD: -2.20; 95% CI -2.97, -1.44), metabolic disorders (WMD: -2.74; 95% CI -3.48, -2.00), and sleep disorders (WMD: -0.67; 95% CI -0.98, -0.37), but not in those with mental disorders, neurodegenerative diseases, and other diseases.
Fatemeh G, Sajjad M, Niloufar R, et al. J Neurol, 2022. PMID 33417003
2022 / Technical systematic review of observational and clinical data
Researchers systematically reviewed evidence from inception through January 2021 examining soy or isoflavone intake and endocrine endpoints across 417 reports (229 observational studies, 157 clinical studies, and 32 systematic reviews and meta-analyses). Isoflavone intake was found not to adversely affect thyroid function, breast or endometrial tissue, estrogen levels in women, or testosterone, estrogen, or sperm and semen parameters in men. Menstrual cycle length was slightly increased without preventing ovulation, and data on in utero exposure and children were reassuring though limited. The authors concluded that evidence does not support classifying isoflavones as endocrine disruptors.
Messina M, Mejia SB, Cassidy A, et al. Crit Rev Food Sci Nutr, 2022. PMID 33775173
2022 / Systematic review and meta-analysis of observational studies
A meta-analysis evaluated observational studies comparing depression outcomes in vegetarians and nonvegetarians. Combining 9 effect sizes showed that adherence to a vegetarian diet was associated with a 53% greater risk of depression compared with omnivores (OR, 1.53; 95% CI, 1.14-2.07; I2 = 69.1%). Positive associations were found for semivegetarian diets (OR, 1.86; 95% CI, 1.42-2.44) and studies in Europe and the US (OR, 1.45; 95% CI, 1.06-1.98), whereas null associations were found for lacto-ovo vegetarians and Asian countries. Comparison of mean depression scores showed no difference (n = 16; SMD, 0.10; 95% CI, -0.01 to 0.21; I2 = 79.1%), and authors noted the findings were not robust.
Shows an association, not proof of cause and effect.
Fazelian S, Sadeghi E, Firouzi S, et al. Nutr Rev, 2022. PMID 33822140
2022 / Systematic review and meta-analysis of prospective cohort studies
A systematic review and meta-analysis of 12 prospective cohort studies examined adherence to plant-based diets and mortality risk in 508,861 participants. The highest versus lowest category of adherence to plant-based diets had a hazard ratio of 0.90 (95% CI: 0.82, 0.99) for all-cause mortality and 0.77 (95% CI: 0.70, 0.86) for CHD mortality. All-cause mortality was also inversely associated with healthy plant-based (HR 0.92; 95% CI: 0.88, 0.96), Pesco-vegetarian (HR 0.81; 95% CI: 0.70, 0.92), and Pro-vegetarian (HR 0.74; 95% CI: 0.55, 0.88) diets. Vegetarian diets were associated with lower cardiovascular mortality (HR 0.92; 95% CI: 0.85, 0.99) and CHD mortality (HR 0.76; 95% CI: 0.68, 0.85). The authors noted limitations in some included studies, warranting further research.
Shows an association, not proof of cause and effect.
Jafari S, Hezaveh E, Jalilpiran Y, et al. Crit Rev Food Sci Nutr, 2022. PMID 33951994
2022 / Systematic review of interventional trials
A systematic review of 84 interventional trials (RCTs and non-randomized trials lasting at least 4 weeks) evaluated the efficacy of plant-predominant diets for treating obesity and cardiometabolic sequelae. In general, plant-based diets demonstrated improved weight control, lipids, cardiovascular end points, blood pressure, insulin sensitivity, A1C, fasting glucose, and a lower risk of diabetes compared with usual diets and in some cases standard health-oriented diets. Preliminary studies suggested that plant-predominant diets within healthy lifestyle interventions may stabilize or even reverse type 2 diabetes and cardiovascular disease. Acceptability and sustainability were generally similar to other health-oriented diets.
Remde A, DeTurk SN, Almardini A, et al. Nutr Rev, 2022. PMID 34498070
2022 / Systematic review and meta-analysis
A systematic review and meta-analysis of 7 clinical and 27 preclinical studies evaluated the effect of Arthrospira (Spirulina) on glycemic and lipid markers. In clinical studies, Arthrospira significantly reduced fasting blood sugar (MD -1.77, 95% CI -2.90 to -0.63), total cholesterol (MD -2.54, 95% CI -4.61 to -0.46), and triglycerides (MD -3.71, 95% CI -6.54 to -0.89), while increasing HDL-C (MD 2.27, 95% CI 0.67 to 3.86). However, it did not significantly reduce HbA1c (MD -0.59, 95% CI -2.23 to 1.04) or LDL-C in humans. Subgroup analyses showed significant FBS reductions with doses under 2 grams [-3.22 (-5.67, -0.76)] and durations under 2 months [-2.52 (-4.37, -0.67)].
Ghanbari F, Amerizadeh A, Behshood P, et al. Curr Probl Cardiol, 2022. PMID 34538515
2022 / Systematic review and dose-response meta-analysis of controlled trials
A systematic review and dose-response meta-analysis of controlled clinical trials evaluated the impact of taurine supplementation on inflammatory and oxidative stress biomarkers. Taurine significantly decreased levels of MDA (SMD = -1.17 µmol/l; 95% CI: -2.08, -0.26; P = 0.012) and CRP (SMD = -1.95 mg/l; 95% CI: -3.20, -0.71; P = 0.002). No significant effects were observed for TNF-α (SMD = -0.18 pg/ml; 95% CI: -0.56, 0.21; P = 0.368) or IL-6 (SMD = -0.49 pg/ml; 95% CI: -1.13, 0.16; P = 0.141). Time-response analysis showed a more pronounced alleviating effect at 56 days (8 weeks) after supplementation (P < 0.05).
Faghfouri AH, Seyyed Shoura SM, Fathollahi P, et al. Eur J Clin Nutr, 2022. PMID 34584225
2022 / Meta-analysis of randomized controlled trials
A meta-analysis evaluated the effect of curcumin supplementation on CRP (9 studies) and hs-CRP (23 studies) in patients with autoinflammatory conditions. Curcumin significantly decreased CRP compared to placebo (WMD = -3.67 mg/L, 95% CI = -6.96 to -0.38, p = 0.02), with significant effects at doses ≤1,000 mg/day and interventions >10 weeks. hs-CRP was also significantly lower than placebo, showing significant effects at doses ≤1,000 mg/day and durations ≤10 weeks, reducing hs-CRP in a non-linear fashion with stronger effects at less than 2,000 mg/day.
Gorabi AM, Abbasifard M, Imani D, et al. Phytother Res, 2022. PMID 34586711
2022 / Systematic review of in vitro, animal, and human observational studies
A systematic review of 22 studies (3 in vitro, 8 animal, and 11 human observational studies) examined links between vitamin B-12 intake, status, or supplementation and the gut microbiome. Nineteen studies reported associations with gut microbiome outcomes, such as alpha-diversity, beta-diversity, relative bacterial abundance, functional capacity, or short-chain fatty acid production. While in vitro studies suggested vitamin B-12 may increase alpha-diversity and shift composition, findings from animal and human observational studies were heterogeneous. The authors noted that few prospective observational studies and no randomized trials in humans have been conducted.
Shows an association, not proof of cause and effect.
Guetterman HM, Huey SL, Knight R, et al. Adv Nutr, 2022. PMID 34612492
2022 / Systematic review
This PRISMA-guided systematic review examined the relationship between epilepsy/antiseizure medications and non-alcoholic drinks across 50 included studies (17 human studies, 11 case reports/series, and 22 animal/in vitro studies). None of the included studies provided class 1 evidence. Limited evidence suggests certain beverages, such as caffeinated energy drinks, might trigger seizures. The authors note that coffee/tea consumption is not harmful up to 200 mg caffeine in one sitting or 400 mg daily, while excessive intake of certain fruit juices (e.g., grapefruit, lime, pomegranate, kinnow, star fruit) and caffeinated drinks should be avoided.
Shows an association, not proof of cause and effect.
Asadi-Pooya AA, Zeraatpisheh Z, Rostaminejad M, et al. Acta Neurol Scand, 2022. PMID 34694642
2022 / Systematic review and meta-analysis of RCTs
A systematic review and meta-analysis evaluated five randomized controlled trials including 1049 participants with metabolic syndrome to assess the effects of synbiotic interventions. Synbiotic supplementation significantly reduced serum insulin (WMD -6.39 μU/mL), triglycerides (WMD -20.3 mg/dl), total cholesterol (WMD -7.8 mg/dl), LDL cholesterol (WMD -9.02 mg/dl), waist circumference (WMD -4.04 cm), body weight (WMD -4.3 kg), systolic blood pressure (WMD -1.8 mmHg), and IL-6 (WMD -0.2 pg/mL), while increasing HDL cholesterol (WMD 2.3 mg/dl). No significant effects were observed for fasting plasma glucose, HOMA-IR, BMI, diastolic blood pressure, heart rate, or C-reactive protein.
Arabi SM, Bahrami LS, Rahnama I, et al. Pharmacol Res, 2022. PMID 34999222
2022 / Systematic review and meta-analysis of prospective cohorts
A systematic review and meta-analysis of 11 prospective cohort studies with 323,788 participants and 28,837 incident cases evaluated dietary iron and type 2 diabetes risk. Higher heme iron consumption was associated with a 20% greater risk of diabetes (RR 1.20, 95% CI 1.07 to 1.35), with each 1 mg/day increment linked to a 16% risk increase (RR 1.16, 95% CI 1.03 to 1.30). Total, non-heme, and supplemental iron showed no significant associations.
Shows an association, not proof of cause and effect.
Shahinfar H, Jayedi A, Shab-Bidar S Eur J Nutr, 2022. PMID 35107626
2022 / Systematic review and meta-analysis
A systematic review and meta-analysis of 52 studies evaluated cold-water immersion (CWI) versus passive recovery following acute strenuous exercise in physically active participants. CWI improved muscular power 24 hours after eccentric exercise (SMD 0.34 [95% CI 0.06-0.62]) and high-intensity exercise (SMD 0.22 [95% CI 0.004-0.43]). Following high-intensity exercise, CWI also reduced serum CK (SMD -0.85 [95% CI -1.61 to -0.08]), decreased muscle soreness (SMD -0.89 [95% CI -1.48 to -0.29]), and enhanced perceived recovery (SMD 0.66 [95% CI 0.29-1.03]) at 24 hours, but had no significant effect on strength recovery. Meta-regression indicated that shorter durations and lower temperatures conferred greater benefits on serum CK and endurance performance.
Moore E, Fuller JT, Buckley JD, et al. Sports Med, 2022. PMID 35157264
2022 / Dose-response meta-analysis of prospective cohort studies
A dose-response meta-analysis of 19 prospective cohort studies evaluated the link between egg intake and mortality in 1,737,893 participants. An increase of 1 egg/day was associated with pooled hazard ratios of 1.08 (95% CI, 1.01-1.15) for all-cause mortality, 1.07 (95% CI, 0.97-1.18) for cardiovascular disease mortality, and 1.16 (95% CI, 1.04-1.30) for cancer mortality. Nonlinear dose-response associations were identified for all three mortality outcomes. The positive association with all-cause mortality was more pronounced in studies adjusting for blood cholesterol-related covariates (Pinteraction = 0.011), though the overall certainty of evidence was rated as very low.
Shows an association, not proof of cause and effect.
Yang PF, Wang CR, Hao FB, et al. Nutr Rev, 2022. PMID 35178575
2022 / Systematic review of randomized controlled trials
A systematic review searched six databases through August 2021 for randomized, placebo-controlled trials examining resveratrol supplementation, alone or with glucose and malate (RGM), in patients with Alzheimer's disease. Four RCTs met the inclusion criteria and were included in qualitative analyses. The authors noted that human studies remain few, but reported that included trials showed this polyphenol acts in delaying cognitive impairment when given alone or as RGM, and seems to influence progressive cognitive and functional decline compared with placebo.
Tosatti JAG, Fontes AFDS, Caramelli P, et al. Drugs Aging, 2022. PMID 35187615
2022 / Systematic review and meta-analysis of prospective cohort studies
A systematic review and meta-analysis of 40 prospective cohort studies including 5,750,133 individuals evaluated the association between ultra-processed food (UPF) intake and all-cause mortality. Highest consumption of UPF was associated with an increased risk of mortality (RR = 1.29, 95% CI: 1.17, 1.42), as was intake of sugar-sweetened beverages (RR = 1.11, 95% CI: 1.04, 1.18), artificially sweetened beverages (RR = 1.14, 95% CI: 1.05, 1.22), and processed meat/red meat (RR = 1.15, 95% CI: 1.10, 1.21). In contrast, breakfast cereals were associated with a lower mortality risk (RR = 0.85, 95% CI: 0.79, 0.92). The authors note a lack of standardized methods in UPF categorization as an area for future research.
Shows an association, not proof of cause and effect.
Taneri PE, Wehrli F, Roa-Díaz ZM, et al. Am J Epidemiol, 2022. PMID 35231930